✦ LIBER ✦

Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

✍ Scribed by Scott, R.; O'Brien, R.; Fulcher, G.; Pardy, C.; d'Emden, M.; Tse, D.; Taskinen, M.-R.; Ehnholm, C.; Keech, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of fenofibrate on cardiovascular

✍ Andrew Tonkin; David Hunt; Merryn Voysey; Antero Kesäniemi; Andrew Hamer; Jonath 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Effects of fenofibrate on renal function

✍ T. M. E. Davis; R. Ting; J. D. Best; M. W. Donoghoe; P. L. Drury; D. R. Sullivan 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 320 KB

Risk Predictors of Lower-limb Amputation

✍ K. Rajamani; L. Li; J. Best; M. Voysey; R. Ting; M. D’Emden; M. Laakso; J. Baker 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Estimated glomerular filtration rate and

✍ P. L. Drury; R. Ting; D. Zannino; C. Ehnholm; J. Flack; M. Whiting; R. Fassett; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 246 KB

Effects of long-term fenofibrate therapy

📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 186 KB

Impact of metabolic syndrome and its com

✍ Russell Scott; Mark Donoghoe; Gerald F Watts; Richard O’Brien; Christopher Pardy 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 177 KB